These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10090425

  • 21. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
    Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, Benson K, Leighton J, Kim SK, Wood R, Rothmann M, Chen G, U KM, Staten AM, Pazdur R.
    Clin Cancer Res; 2002 May; 8(5):935-42. PubMed ID: 12006504
    [Abstract] [Full Text] [Related]

  • 22. [Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
    Pneumologie; 1997 Sep; 51(9 Suppl):1-4. PubMed ID: 9417540
    [No Abstract] [Full Text] [Related]

  • 23. Postmarketing experience with auranofin in the Federal Republic of Germany.
    Schattenkirchner M, Missler B, Mulz D.
    Scand J Rheumatol Suppl; 1986 Sep; 63():57-66. PubMed ID: 3299683
    [Abstract] [Full Text] [Related]

  • 24. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
    O'Doherty B, Dutchman DA, Pettit R, Maroli A.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():73-81. PubMed ID: 9484876
    [Abstract] [Full Text] [Related]

  • 25. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB.
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [Abstract] [Full Text] [Related]

  • 26. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK, Triller DM, Yong CS, Lodise TP.
    Ann Pharmacother; 2004 Jun; 38(7-8):1226-35. PubMed ID: 15187209
    [Abstract] [Full Text] [Related]

  • 27. Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.
    Geddes AM.
    Expert Opin Investig Drugs; 1999 Apr; 8(4):487-505. PubMed ID: 15992094
    [Abstract] [Full Text] [Related]

  • 28. Grepafloxacin--a new fluoroquinolone.
    Med Lett Drugs Ther; 1998 Jan 30; 40(1019):17-8. PubMed ID: 9465856
    [No Abstract] [Full Text] [Related]

  • 29. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov 30; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 30. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Cranfield R, Breisch S, Pettit R.
    J Antimicrob Chemother; 1997 Dec 30; 40 Suppl A():63-72. PubMed ID: 9484875
    [Abstract] [Full Text] [Related]

  • 31. Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.
    Goa KL, Bryson HM, Markham A.
    Drugs; 1997 Apr 30; 53(4):700-25. PubMed ID: 9098667
    [Abstract] [Full Text] [Related]

  • 32. Sparfloxacin: a review.
    Schentag JJ.
    Clin Ther; 2000 Apr 30; 22(4):372-87; discussion 371. PubMed ID: 10823360
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections.
    Khashab MM, Xiang J, Kahn JB.
    Curr Med Res Opin; 2006 Oct 30; 22(10):1997-2006. PubMed ID: 17022859
    [Abstract] [Full Text] [Related]

  • 34. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun 12; 34(872):58-60. PubMed ID: 1317502
    [No Abstract] [Full Text] [Related]

  • 35. Safety of the new fluoroquinolones compared with ciprofloxacin.
    Ball P.
    J Chemother; 2000 Jan 12; 12 Suppl 1():8-11. PubMed ID: 11414383
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
    Rizk E.
    Am J Med; 1992 Apr 06; 92(4A):130S-135S. PubMed ID: 1316063
    [Abstract] [Full Text] [Related]

  • 39. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C.
    J Antimicrob Chemother; 1999 Oct 06; 44(4):515-23. PubMed ID: 10588313
    [Abstract] [Full Text] [Related]

  • 40. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin.
    Ferguson J, Dawe R.
    J Antimicrob Chemother; 1997 Dec 06; 40 Suppl A():93-8. PubMed ID: 9484878
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.